LENZ THERAPEUTICS INC (LENZ) Stock Analyst Ratings
NASDAQ:LENZ - Nasdaq - US52635N1037 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to LENZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 45.03. This target is 52.53% above the current price.
LENZ was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about LENZ.
In the previous month the buy percentage consensus was at a similar level.
LENZ was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-20 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-27 | Raymond James | Initiate | Outperform |
| 2024-08-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Initiate | Buy |
| 2024-04-15 | Leerink Partners | Initiate | Outperform |
| 2024-04-15 | William Blair | Initiate | Outperform |
| 2024-04-10 | Citigroup | Initiate | Buy |
| 2024-03-27 | Piper Sandler | Initiate | Overweight |